Response of Australian veterinarians to the announcement of a Hendra virus vaccine becoming available.

The research is about the responses of private veterinarians in Queensland, Australia to the introduction of a Hendra virus vaccine for horses, revealing a majority support for its implementation, yet noting it won’t replace current management and infection control measures.

Overview of the Study

• The research was a cross-sectional study conducted among private veterinarians in Queensland, Australia who are providing equine services. A cross-sectional study is a type of observational research that analyzes data from a population, or a representative subset, at a specific point in time.
• The objective was to gauge their response towards the introduction of a Hendra virus vaccine. The Hendra virus is a highly lethal zoonotic virus in horses that can also lead to serious disease in humans exposed to horses infected with the virus.

Findings of the Study

• The study revealed that a majority of the responding veterinarians supported the introduction of a Hendra virus vaccine, showing a positive acceptance of this initiative. Notably, nearly half of the respondents expressed the intention to require the vaccination as a prerequisite for a horse patient presentation, indicating a substantial initial level of support for the vaccination campaign.
• Despite this widespread manifestation of support for the vaccine, the studied veterinarians also voiced that the introduction of a vaccine alone would not sufficiently reduce the risk to warrant downgrading or discontinuing their current Hendra Virus management plan and infection control measures. This suggests that the veterinarians consider the vaccine as an additional layer of protection against the virus rather than a complete solution.

Conclusions

• The authors concluded that the intentions of private veterinarians should be seen as a significant driver for the uptake of the Hendra virus vaccine. As a result, when developing promotional and marketing campaigns for the Hendra virus vaccine, government agencies and manufacturers should consider these intentions and beliefs.
• Given the inherent risk that the Hendra virus poses to both horses and humans, fostering a cooperative relationship between agencies, manufacturers and veterinarians can potentially contribute to a more effective and comprehensive management strategy against the virus.